Michalopoulou & Associates Lawgroup in cooperation with Pytheia – the Competence Center in Greece in the field of Health – organizes the most valuable official seminar, which provides the knowledge required before any researchor development of Medical Devices and Software as Medical Devices. This course is addressed to all stakeholders in the medical device supply
The 2nd webinar on dietary supplements and the legislation governing their circulation and distribution was successfully held yesterday. It was delivered by our associate Giorgos Skampoulos LL.M.
The 2nd webinar on dietary supplements and the legislation governing their circulation and distribution was successfully held yesterday. It was delivered by our associate Giorgos Skampoulos LL.M.
Proud to be part of the Biotech evolution in Greece. An evolution with data at its epicenter. From patients’ and health care professionals’ to clinical trials’ and medical institutions’ data, Artificial Intelligence requires data volume, yet privacy laws pose restrictions. Our Managing Partner Ioanna Michalopoulou will be speaking on how to navigate this oxymoron, giving legal pointers on Data Privacy,

Lawyer October 2021

Artificial Intelligence, its applications and the demands posed by Reg. 2017/745 (MDR) on medicaldevices manufactures and HP, was the core question set by Alexianna Tsotsou to our Managing Partner Ioanna Michalopoulou, as part of LAWYER | The Business Magazine’s research on artificialintelligence and the way it is shaping the new EU legal landscape for health. You can access the entire article, in the October 2021 issue

2020 Food Safety Conference

Future of Healthcare in Cyprus

Ioanna Michalopoulou shares her views on the transformative changes brought about by Covid19 in Business and Law in Greece, with esteemed colleagues
The White Paper on Artificial Intelligence published on February 19th by the European Commission presents some important building block policy options. These enable a trustworthy and secure development of artificial intelligence in the EU, fully respecting the presiding values and the fundamental rights of its citizens. The enormous volume of data which has already been
Our firm’s approach on Genomic research and data protection in view of the CRISPR technology. You may read our article below: https://lawgroup.gr/wp-content/uploads/2020/03/Healthcare-and-Life-Sciences-Law-Sept-2019.pdf “This article first appeared on the website of the Healthcare and Life Sciences Law Committee of the Legal Practice Division of the International Bar Association, and is reproduced by kind permission of the
legal breakthrough
Michalopoulou & Associates successfully represented a medical devices company on dispute arising from the enforcement of a monetary amount on behalf of EOPYY related to the reimbursement of specific expendable medical supplies (medical dressings). Our team successfully proved before the competent court that the enforced monetary amount did not include sufficient and unambiguous justification in
Ms Michalopoulou and Ms Chatziantoniou have contributed to this year’s edition on the compliance of pharmaceutical companies with the local and European legislation and in particular the current legislative framework in Greece for providing information prior authorization of a medicinal product, advertising to healthcare professionals (HCPs), gifts and hospitality, regarding transparency and disclosure status as